ClinicalTrials.Veeva

Menu

Cardiac Biomarkers After Marathon Running and Coronary Atherosclerosis (MaraCat)

U

University of Turku

Status

Completed

Conditions

Coronary Artery Disease

Study type

Observational

Funder types

Other

Identifiers

NCT03738631
T171/2018

Details and patient eligibility

About

This study evaluates cardiac biomarkers and their association to coronary artery disease in marathon runners.

Full description

The MaraCat study is an observational prospective study evaluating the association between cardiac biomarkers and coronary artery disease in 43 runners participating in the 2018 Paavo Nurmi Marathon. The study participants were recruited according to two age criteria - under 35 years and over 44 years of age. Comprehensive laboratory samples were collected immediately after the run, while the control workup was done in a separate visit with no significant physical excercise in the preceding two weeks. In the under 35 years -group, the control workup included an echocardiography, ecg and blood samples. In the over 44 years group, the control studies included coronary CT, echocardiography, ecg and laboratory tests.

Enrollment

43 patients

Sex

Male

Ages

35 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age under 35 years or over 44 years
  • Participant of Paavo Nurmi Marathon 2018
  • Informed consent signed

Exclusion criteria

  • No informed consent
  • existing coronary artery disease

Trial design

43 participants in 2 patient groups

Under 35 years
Over 44 years

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems